Opendata, web and dolomites


Easy-to-use and highly accurate medical software for quantitative assessment of impairments in neurologically injured people.

Total Cost €


EC-Contrib. €






 ReHaptix project word cloud

Explore the words cloud of the ReHaptix project. It provides you a very rough idea of what is the project "ReHaptix" about.

disorders    standard    software    supply    optimize    designed    diseases    lack    worldwide    recovery    feasibility    innovation    schedule    functional    population    evidences    strategy    medication    private    remote    clinical    expensive    setting    gold    performing    neurological    objectively    ce    grow    supervised    rehaptix    aged    caused    drafted    parkinson    device    injured    treatment    doctor    app    touchscreen    market    mhealth    validated    mark    appointment    hospital    drastically    healthcare    professionals    stroke    remotely    chain    assessments    percentage    tests    accuracy    validity       chronic    limited    initiated    hcps    greatest    validation    neurologically    tablet    30m    share    sclerosis    disease    solutions    treating    multiple    quantitative    empowers    impairments    adapt    patients    obtain    ms    monitor    perform    rehabilitation    65    clinically    home    people    autonomously    25    trials    either    plan    clinic    medical    progress   

Project "ReHaptix" data sheet

The following table provides information about the project.


Organization address
city: ZURICH
postcode: 8004
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-09-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    REHAPTIX GMBH CH (ZURICH) coordinator 50˙000.00


 Project objective

Neurological disorders, caused by either stroke, multiple sclerosis (MS) or Parkinson’s diseases affect more than 30M people worldwide. Currently, Europe has the greatest percentage of population aged 65 or over (25%) and these numbers are expected to drastically grow (3% per year) increasing the population affected by these chronic conditions. Neurological rehabilitation is an expensive doctor-supervised program designed for treating these diseases. However, there is currently no effective assessment to objectively measure and monitor the rehabilitation progress. Current solutions for performing assessments do not provide clinical evidences of their validity, show lack of accuracy and are limited to one disease type. ReHaptix has developed a medical software, designed for remote quantitative assessment of impairments in neurologically injured people. ReHaptix has developed 9 tests so far, of which 4 have been clinically validated (the gold standard), and 5 are currently under clinical validation. Healthcare Professionals (HCPs) can use the ReHaptix tests to evaluate their patients in the hospital, rehabilitation clinic or private practice, or patients can perform the tests autonomously at home on a touchscreen tablet, which empowers them about their recovery. Furthermore, patients can remotely share their results with their HCPs, who can adapt the treatment and medication, or schedule medical appointment and home-setting assessments as required. During the feasibility assessment, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. During the second phase of innovation project, ReHaptix will optimize the software increasing the number of tests and developing a functional mHealth app. Clinical trials will then be initiated to obtain the CE mark as a medical device.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REHAPTIX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REHAPTIX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Presque (2019)

Smart Nursing Bra

Read More